LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 5.44 | 770.25 | 982 | 1012 | 0.9696 | 0.8498 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 7.66 | 770.25 | 1075 | 1090 | 0.9862 | 0.9454 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 7.66 | 770.25 | 1090 | 1090 | 1.0000 | 1.0000 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 10.06 | 770.25 | 1168 | 1218 | 0.9586 | 0.8761 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 10.06 | 770.25 | 1174 | 1218 | 0.9635 | 0.8907 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 12.28 | 770.25 | 1258 | 1358 | 0.9263 | 0.8213 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 12.28 | 770.25 | 1285 | 1358 | 0.9462 | 0.8692 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 14.50 | 770.25 | 1346 | 1497 | 0.8990 | 0.7898 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 14.50 | 770.25 | 1408 | 1497 | 0.9404 | 0.8758 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 16.73 | 770.25 | 1384 | 1664 | 0.8315 | 0.6941 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 16.73 | 770.25 | 1435 | 1664 | 0.8621 | 0.7501 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 18.95 | 770.25 | 1433 | 1832 | 0.7820 | 0.6429 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 18.95 | 770.25 | 1517 | 1832 | 0.8278 | 0.7195 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 21.17 | 770.25 | 1472 | 2008 | 0.7329 | 0.5975 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 21.17 | 770.25 | 1568 | 2008 | 0.7807 | 0.6722 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 23.39 | 770.25 | 1581 | 2244 | 0.7044 | 0.5937 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 23.39 | 770.25 | 1659 | 2244 | 0.7391 | 0.6442 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 25.62 | 770.25 | 1626 | 2514 | 0.6466 | 0.5491 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 25.62 | 770.25 | 1769 | 2514 | 0.7034 | 0.6275 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 27.84 | 770.25 | 1727 | 2833 | 0.6094 | 0.5367 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 27.84 | 770.25 | 1861 | 2833 | 0.6567 | 0.5990 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 30.06 | 770.25 | 1835 | 3106 | 0.5908 | 0.5396 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 30.06 | 770.25 | 2006 | 3106 | 0.6458 | 0.6093 | MN20160304_L02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 32.28 | 770.25 | 1956 | 3392 | 0.5765 | 0.5460 | MN20160304_L02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 32.28 | 770.25 | 2106 | 3392 | 0.6207 | 0.6003 | MN20160304_L02 | L09 |